Paion Competitors and Similar CompaniesClear all
Paion's competitors and similar companies include ObsEva, Affimed N.V. and Avid Bioservices.
 Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. |  ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine. |  Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | |
Founding Date | Founding Date 2000 | Founding Date 2012 | Founding Date 2000 | Founding Date 1981 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US | Locations Heidelberg, DE HQ | Locations Tustin, US HQ |
Employees | Employees 3218% decrease | Employees 811% decrease | Employees 76 | Employees 21114% increase |
Valuation ($) | Valuation ($) 49.7 m | Valuation ($) N/A | Valuation ($) 52.5 m | Valuation ($) 649.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) €33.2m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $139.9m (FY, 2024) |
Cost of goods | Cost of goods €382k (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods $132.6m (FY, 2024) |
Gross profit | Gross profit €33.4m (FY, 2022) | Gross profit N/A | Gross profit €13m (FY, 2023) | Gross profit $7.3m (FY, 2024) |
Net income | Net income (€579k) (FY, 2022) | Net income N/A | Net income (€105.9m) (FY, 2023) | Net income ($140.8m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 15.2m | Total funding raised $ 92.9m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ObsEva
HQ
Plan-les-Ouates, CH
Employees
8↓ 11% decrease
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
View companyAffimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View companyAvid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company